KPV Immobilized on Surfaces Still Blocks NF-κB: Anti-Inflammatory Peptide Coatings

Alpha-MSH analog GKPV immobilized on surfaces inhibited TNF-α-stimulated NF-κB activation in cells, demonstrating that KPV-related peptides retain anti-inflammatory activity when attached to biomaterial surfaces — enabling anti-inflammatory medical device coatings.

Kelly, J M et al.·Peptides·2006·Preliminary Evidencein-vitro
RPEP-01151In VitroPreliminary Evidence2006RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

GKPV (alpha-MSH 10-13) immobilized on surfaces retained NF-κB inhibitory activity against TNF-α-stimulated inflammation in vitro, demonstrating that KPV-related peptides can function as bioactive anti-inflammatory coatings for medical devices and implants.

Key Numbers

How They Did This

in-vitro study on kpv, inflammation.

Why This Research Matters

Relevant for kpv, inflammation.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding GKPV (alpha-MSH 10-13) immobilized on surfaces retained NF-κB inhibitory activity against TNF-α-stimulated inflammation in vitro, demonstrating that K
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2006.
Original Title:
Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-alpha stimulated NF-kappaB activity.
Published In:
Peptides, 27(2), 431-7 (2006)
Database ID:
RPEP-01151

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

KPV Immobilized on Surfaces Still Blocks NF-κB: Anti-Inflammatory Peptide Coatings

What was found?

Alpha-MSH analog GKPV immobilized on surfaces inhibited TNF-α-stimulated NF-κB activation in cells, demonstrating that KPV-related peptides retain anti-inflammatory activity when attached to biomaterial surfaces — enabling anti-inflammatory medical device coatings.

Read More on RethinkPeptides

Cite This Study

RPEP-01151·https://rethinkpeptides.com/research/RPEP-01151

APA

Kelly, J M; Moir, A J G; Carlson, K; Yang, Y; MacNeil, S; Haycock, J W. (2006). Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-alpha stimulated NF-kappaB activity.. Peptides, 27(2), 431-7.

MLA

Kelly, J M, et al. "Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-alpha stimulated NF-kappaB activity.." Peptides, 2006.

RethinkPeptides

RethinkPeptides Research Database. "Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV..." RPEP-01151. Retrieved from https://rethinkpeptides.com/research/kelly-2006-immobilized-alphamelanocyte-stimulating-hormone

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.